Single nucleotide polymorphisms (SNPs): History, biotechnological outlook and practical applications

Current Pharmacogenomics

Volumn 3, Issue 3, 2005, Pages 237-245

  Kassam, Shelina ^a   Meyer, Peter ^b,c   Corfield, Anthony ^d   Mikuz, Gregor ^e   Sergi, Consolato ^a,e  

^a ST MICHAEL'S HOSPITAL   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Laboratories for Molecular Oncogenetics   (Germany)

^d BRISTOL ROYAL INFIRMARY   (United Kingdom)

^e UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

DNA microarray; Genotyping; Pharmacogenetics; Pharmacogenomics; Polymerase chain reaction; Restriction fragment length polymorphisms; Single nucleotide polymorphisms

Indexed keywords

BIOTECHNOLOGY; DIAGNOSTIC TEST; DNA SEQUENCE; DRUG DESIGN; DRUG MECHANISM; DRUG RESPONSE; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; GENOMICS; HISTORY; HUMAN; MOLECULAR BIOLOGY; PATIENT CODING; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 23844498305     PISSN: 15701603     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570160054864021     Document Type: Review

References (40)

1. Altman, R. B. and Klein, T. E. (2002) Challenges for biomedical informatics and pharmacogenomics. Ann. Rev. Pharmacol. Toxicol. 42, 113-133.
2. Ambrose, H. J. (2002) SNPs and Pharmacogenomics. Pharmacogenomics 3, 583-586.
3. Barr, C. L.; Lichter, J. B. and Kidd, K. K. Approaches used to localize disease genes: Polymorphism mapping. In Molecular Diagnostics; Rapley R. and Walker M. R.; Eds; Blackwell Scientific Publications: Oxford, 66-75.
4. Behnke, D.; Raida, M.; Kliche, K. O. and Pichlmeier, U. (2002) Clin. Cancer Res. 8, 1315-1316.
5. Beutler, E. (1993) Study of glucose-6-phosphate dehydrogenase: history and molecular biology. Am. J. Hematol. 42, 53-58.
6. Brookes, A. J.; Lehvaslaiho, H.; Siegfried, M.; Boehm, J. G.; Yuan, Y. P.; Sarkar, C. M.; Bork, P. and Ortigao, F. (2000) HGBASE: a database of SNPs and other variations in and around human genes. Nucleic Acids Res. 28, 356-360.
7. Buetow, K. H.; Edmonson, M.; MacDonald, R.; Clifford, R.; Yip, P. and Kelley, J. Little, D. P.; Strausberg, R.; Koester, H.; Cantor, C. R. and Braun, A. (2001) High-throughput development and characterization of a genome wide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc. Natl. Acad. Sci. USA 98, 581-584.
8. Cairncross, J. G.; Ueki, K.; Zlatescu, M. C.; Lisle, D. K.; Finkelstein, D. M.; Hammond, R. R.; Silver, J. S.; Stark, P. C.; Macdonald, D. R.; Ino, Y; Ramsay, D. A. and Louis, D. N. (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst. 90, 1473-1479.
9. Davies, P. (1986) The genetics of Alzheimer's disease: a review and a discussion of the implications. Neurobiol. Aging. 7, 459-466.
10. Desta, Z.; Wu, G. M.; Morocho, A. M.; Flockhart, D. A. (2002) The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6. Drug Metab. Dispos. 3, 336-343.
11. Desta, Z.; Zhao, X.; Shin, J. G.; Flockhart, D. A. (2002) Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin. Pharmacokinet. 41, 913-958.
12. Drysdale, C. M.; McGraw, D. W.; Stack, C. B.; Stephens, J. C.; Judson, R. S.; Nandabalan K.; Arnold K.; Ruano G. and Liggett, S. B. (2000) Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl. Acad. Sci. USA 97, 10483-10488.
13. Ezquerra, M.; Lleo, A.; Castellvi, M.; Queralt, R.; Santacruz, P.; Pastor, P.; Molinuevo, J. L.; Blesa, R. and Oliva, R. (2003) A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease. Arch. Neurol. 60, 1149-1151.
14. Fischer, J.; Schwab, M.; Eichelbaum, M. and Zanger, U. M. (2003) Mutational analysis of the human dihydropyrimidine dehydrogenase gene by denaturing high-performance liquid chromatography. Genet. Test. Summer 7, 97-105.
15. Fredman, D.; Siegfried, M., Yuan, Y. P., Bork, P.; Lehvaslaiho, H. and Brookes, A. J. (2002) HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources. Nucleic Acids Res. 30, 387-391.
16. Gross, E.; Seck, K.; Neubauer, S.; Mayr, J.; Hellebrand, H.; Ratanaphan, A.; Lutz, V.; Stockinger, H. and Kiechle, M. (2003) High-throughput genotyping by DHPLC of the dihydropyrimidine dehydrogenase gene implicated in (fluoro)pyrimidine catabolism. Int. J. Oncol. 22, 325-332.
17. Hakonarson, H.; Bjornsdottir, U. S.; Halapi, E.; Palsson, S.; Adalsteinsdottir, E.; Gislason, D.; Finnbogason, G.; Gislason, T.; Kristjansson, K.; Arnason, T.; Birkisson, I.; Frigge, M. L.; Kong, A.; Gulcher, J. R. and Stefansson, K. (2002) A major susceptibility gene for asthma maps to chromosome 14q24. Am. J. Hum. Genet. 71, 483-491.
18. Hill, A. V. S.; Allsopp, C. E. M.; Kwiatkowski, D.; Anstey, N. M.; Twumasi, P.; Rowe, P. A.; Bennett, S.; Brewster, D.; McMichael, A. J. and Greenwood, B. M. (1991) Common West African HLA antigens are associated with protection from severe malaria. Nature 352, 595-600.
19. Hubbard, T.; Barker, D.; Birney, E.; Cameron, G.; Chen, Y.; Clark, L.; Cox, T.; Cuff, J.; Curwen, V.; Down, T.; Durbin, R.; Eyras, E; Gilbert, J; Hammond, M; Huminiecki, L.; Kasprzyk, A.; Lehvaslaiho, H.; Lijnzaad, P.; Melsopp, C.; Mongin, E.; Pettett, R.; Pocock, M.; Potter, S.; Rust, A.; Schmidt, E.; Searle, S.; Slater, G.; Smith, J.; Spooner, W.; Stabenau, A.; Stalker, J.; Stupka, E.; Ureta-Vidal, A.; Vastrik, I. and Clamp, M. (2002) The Ensembl genome database project. Nucleic Acids Res. 30, 38-41.
20. Kent, W. J.; Sugnet, C. W.; Furey, T. S.; Roskin, K. M.; Pringle, T. H.; Zahler, A. M. and Haussler, D. (2002) The human genome browser at UCSC. Genome Res. 12, 996-1006.
21. Kuhara, T.; Ohdoi, C.; Ohse, M.; van Kuilenburg, A. B.; van Gennip, A. H.; Sumi, S.; Ito, T.; Wada, Y. and Matsumoto, I. (2003) Rapid gas chromatographic-mass spectrometric diagnosis of dihydropyrimidine dehydrogenase deficiency and dihydropyrimidinase deficiency. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 792, 107-115.
22. Lazarou, J.; Pomeranz, B. H. and Corey, P. N. (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279, 1200-1205.
23. Luzzatto, L. and Mehta, A. (1995) Glucose 6-phosphate dehydrogenase deficiency. In The Metabolic and Molecular Bases of Inherited Disease; Scriver, C. R.; Beaudet, A. L.; Sly, W. S. and Valle, D.; Eds.; McGraw-Hill, Inc: New York, pp. 3367-3398.
24. McKusick, V. A. (2003) Online Mendelian Inheritance in Man (OMIM). Center for Medical Genetics, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), http//www3.ncbi.nlm.nih.gov/omim/
25. McLeod, H. L.; Krynetski, E. Y.; Relling, M. V. and Evans W. E. (2000) Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14, 567-572.
26. Mullis, K. B. and Faloona, F. A. (1987) Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 155, 335-350.
27. Nei, M. and Roychoudhury, A. K. (1993) Evolutionary relationships of human populations on a global scale. Mol. Biol. Evol. 10, 927-943.
28. Pettipher, R. and Cardon, L. R. (2002) The application of genetics to the discovery of better medicines. Pharmacogenomics 3, 257-263.
29. Pullarkat, S. T.; Stoehlmacher, J.; Ghaderi, V.; Xiong, Y. P.; Ingles, S. A.; Sherrod, A.; Warren, R.; Tsao-Wei, D.; Groshen, S. and Lenz, H. J. (2001) Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J 1, 65-70.
30. Race, R. R. and Sanger, R. (1975) Blood Groups in Man (Blackwell, Oxford), 6th Ed.
31. Raida, M.; Schwabe, W.; Hausler, P.; Van Kuilenburg, A. B.; Van Gennip, A. H.; Behnke, D. and Hoffken, K. (2001) Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5′-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls. Clin. Cancer Res. 7, 2832-2839.
32. Sachidanandam, R.; Weissman, D.; Schmidt, S. C.; Kakol, J. M.; Stein, L. D.; Marth, G.; Sherry, S.; Mullikin, J. C.; Mortimore, B. J.; Willey, D. L.; Hunt, S. E.; Cole, C. G.; Coggill, P. C.; Rice, C. M.; Ning, Z.; Rogers, J.; Bentley, D. R.; Kwok, P. Y.; Mardis, E. R.; Yeh, R. T.; Schultz, B.; Cook, L.; Davenport, R.; Dante, M.; Fulton, L.; Hillier, L.; Waterston, R. H.; McPherson, J. D.; Gilman, B.; Schaffner, S.; Van Etten, W. J.; Reich, D.; Higgins, J; Daly, M. J.; Blumenstiel, B.; Baldwin, J.; Stange-Thomann, N.; Zody, M. C.; Linton, L.; Lander, E. S. and Altshuler, D. (International SNP Map Working Group). (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928-933.
33. Sarkar, C.; Ortigao, F. R.; Gyllensten, U. and Brookes, A. J. (1998) Human genetic bi-allelic sequences (HGBASE), a database of intragenic polymorphisms. Mem. Inst. Oswaldo Cruz. 93, 693-694.
34. Saunders, A. M. (2001) Gene identification in Alzheimer's disease. Pharmacogenomics 2, 239-249.
35. Stajich, J. E.; Block, D.; Boulez, K.; Brenner, S. E.; Chervitz, S. A.; Dagdigian, C.; Fuellen, G.; Gilbert, J. G.; Korf, I.; Lapp, H.; Lehvaslaiho, H.; Matsalla, C.; Mungall, C. J.; Osborne, B. I.; Pocock, M. R.; Schattner, P.; Senger, M.; Stein, L. D.; Stupka, E.; Wilkinson, M. D and Birney, E. (2002) The Bioperl toolkit: Perl modules for the life sciences. Genome Res. 12, 1611-1618.
36. Stein, L. D. (2002) The Generic Genome Browser: A building block for a model organism system database. Genome Res. 12, 1599-1610.
37. Stein, L. D. and Thierry-Mieg, J. (1998) Scriptable access to the Caenorrhabditis elegans genome sequence and other ACeDB databases. Genome Res. 8, 1308-1315.
38. Thorisson, G. D. and Stein, L. D. (2003) The SNP Consortium website: past, present and future. Nucleic Acids Res. 31, 124-127
39. Van Kuilenburg, A. B. P.; Haasjes, J.; Richel, D. J.; Zoetekouw, L.; Van Lenthe, H.; De Abreu, R. A.; Maring, J. G.; Vreken, P. and van Gennip, A. H. (2000) Clinical implications of dihydropyrimidine de-hydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: iden-tification of new mutations in the DPD gene. Clin. Cancer Res. 6, 4705-4712.
40. Vesell, E. S. and Penno, M. B. (1983) Assessment of methods to identify sources of interindividual pharmacokinetic variations. Clin. Pharmacokinet. 8, 378-409.